Europe — EMA
Palonosetron Stada
Palonosetron, the active ingredient in Palonosetron Stada, is a 5‑HT₃ receptor antagonist presented as a sterile injectable solution for intravenous use.
Request sourcing
What is Palonosetron?
Palonosetron, the active ingredient in Palonosetron Stada, is a 5‑HT₃ receptor antagonist presented as a sterile injectable solution for intravenous use. It is used to prevent chemotherapy‑induced nausea and vomiting in adult cancer patients. GNH USA supplies Palonosetron Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.
What is Palonosetron used for?
Palonosetron is a selective 5‑HT₃ receptor antagonist indicated for the prevention of nausea and vomiting associated with chemotherapy. It helps: - Chemotherapy‑induced nausea and vomiting (CINV): Reduces both acute and delayed episodes. - Post‑operative postoperative ? - Radiotherapy‑ ? - Ant ? - -
What are the side effects of Palonosetron?
The
